98%
921
2 minutes
20
Purpose: To assess the safety and efficacy of thyroid arterial embolization (TAE) and its impact on clinical outcomes and quality of life (QoL) in patients with nodular and multinodular goiter (NG/ MNG).
Materials And Methods: The study included 20 patients with NG/ MNG (16 women, 4 men; mean age, 37 years) who underwent TAE using polyvinyl alcohol (PVA) particles (350-500 μm) between January 2022 and December 2023. Clinical, radiological and quality of life (QoL) assessment (thyPRO-39 questionnaire) were performed at baseline and 6 months post-procedure. Biochemical evaluation with thyroid function tests were done at 1 week, 1 month, 3 months and 6 months post-procedure.
Results: Of 20 patients, 16 had solitary thyroid nodules (STN), while 4 had multinodular goiter (MNG). Three patients had non-Graves hyperthyroidism, while the remainder were euthyroid. Technical success was achieved in all patients. 35 out of 82 interrogated thyroid arteries were seen supplying the nodules and were successfully embolized using PVA particles. At 6 months follow-up, no major complications were reported. Minor complications, including neck pain (60%), fever (20%), toothache (5%) and arm pain (5%) were seen and responded well to conservative management. The median volume of STN/dominant nodule decreased by 63.7%, from 27.5 ml (13.7-59) to 10 ml (7-17.0) (p < 0.001). Goiter score decreased from 40 (34-78.5) to 17.5 (12.5-31.5), hyperthyroid score from 15.5 (10.5-38.5) to 8 (2-13), cosmetic/ appearance score from 43 (28-51) to 1 (1-21), composite score from 26.1 (21.5-40.9) to 17.6 (14.7-26.1), and QoL score from 25 (25-50) to 0 (0-25); all changes were statistically significant (p < 0.001).
Conclusion: TAE is a safe and effective treatment option in the non-surgical management of benign NG/ MNG, significantly improving these patients' clinical outcome and having a favourable impact on quality of life.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00270-025-04055-1 | DOI Listing |
J Intensive Care
September 2025
German Center for Vertigo and Balance Disorders, Ludwig-Maximilians-Universitat (LMU), University Hospital Grosshadern, Munich, Germany.
Background: Survivors of critical illness frequently face physical, cognitive and psychological impairments after intensive care. Sensorimotor impairments potentially have a negative impact on participation. However, comprehensive understanding of sensorimotor recovery and participation in survivors of critical illness is limited.
View Article and Find Full Text PDFHealth Qual Life Outcomes
September 2025
Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, 11149, Saudi Arabia.
BMC Med Educ
September 2025
Department of Learning, Informatics, Management & Ethics (LIME) Widerströmska huset, Karolinska Institutet, Stockholm, Sweden.
Background: Live tissue training (LTT) refers to the use of live anaesthetised animals for the purpose of medical education. It is a type of simulation training that is contentious, and there is an ethical imperative for educators to justify the use of animals. This should include scrutinising educational practices.
View Article and Find Full Text PDFBMC Infect Dis
September 2025
Department Health and Prevention, Institute of Psychology, University of Greifswald, Robert-Blum-Str. 13, Greifswald, 17489, Germany.
Background: Healthcare workers (HCWs) played a crucial role in dealing with the COVID-19 pandemic. In addition to increased workloads, they were confronted with stigmatization due to their work in the health sector.
Methods: Guided by the Health Stigma and Discrimination Framework (HSDF), this study aimed to explore the experiences of stigmatization of HCWs in Germany using semi-structured interviews (N = 34) and investigate effective coping strategies and existing needs in this context.
BMC Health Serv Res
September 2025
Institute of General Practice, Rostock University Medical Center, Doberaner Str. 142, Rostock, 18057, Germany.
Background: Post-viral syndromes, including long- and post-COVID, often lead to persistent symptoms such as fatigue and dyspnoea, affecting patients' daily lives and ability to work. The COVI-Care M-V trial examines whether interprofessional, patient-centred teleconsultations, initiated by general practitioners in cooperation with specialists, can help reduce symptom burden and improve care for patients.
Methods: To evaluate the effectiveness of the intervention under routine care conditions, a cluster-randomised controlled trial is being conducted.